The response of autologous T cells to a human melanoma is dominated by mutated neoantigens, Proc Natl Acad Sci U S A, vol.102, pp.16013-16018, 2005. ,
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer, Science, vol.344, pp.641-645, 2014. ,
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer, N Engl J Med, vol.375, pp.2255-2262, 2016. ,
Genetic basis for clinical response to CTLA-4 blockade in melanoma, N Engl J Med, vol.371, pp.2189-2199, 2014. ,
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial, Lancet, vol.387, 1909. ,
Personalized vaccines for cancer immunotherapy, Science, vol.359, pp.1355-1360, 2018. ,
Towards personalized, tumour-specific, therapeutic vaccines for cancer, Nat Rev Immunol, vol.18, pp.168-182, 2018. ,
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing, Nature, vol.515, pp.572-576, 2014. ,
Mutant MHC class II epitopes drive therapeutic immune responses to cancer, Nature, vol.520, pp.692-696, 2015. ,
An immunogenic personal neoantigen vaccine for patients with melanoma, Nature, vol.547, pp.217-221, 2017. ,
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer, Nature, vol.547, pp.222-226, 2017. ,
Neoantigens in cancer immunotherapy, Science, vol.348, pp.69-74, 2015. ,
Engineering New Approaches to Cancer Vaccines, Cancer Immunol Res, vol.3, pp.836-843, 2015. ,
Improving Vaccine and Immunotherapy Design Using Biomaterials, Trends Immunol, vol.39, pp.135-150, 2018. ,
Engineering patient-specific cancer immunotherapies, Nat Biomed Eng, vol.3, pp.768-782, 2019. ,
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release, Vaccine, vol.32, pp.2882-2895, 2014. ,
Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles, Journal of controlled release : official journal of the Controlled Release Society, vol.226, pp.98-106, 2016. ,
Designer vaccine nanodiscs for personalized cancer immunotherapy, Nat Mater, vol.16, pp.489-496, 2017. ,
Dendritic cell activation and T cell priming with adjuvant-and antigenloaded oxidation-sensitive polymersomes, Biomaterials, vol.33, pp.6211-6219, 2012. ,
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants, Expert review of vaccines, vol.12, pp.747-758, 2013. ,
Structure-based programming of lymph-node targeting in molecular vaccines, Nature, vol.507, pp.519-522, 2014. ,
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 ,
, Cancer Immunol Immunother, vol.62, pp.787-799, 2013.
Toll-like Receptor Agonist Conjugation: A Chemical Perspective, Bioconjug Chem, vol.29, pp.587-603, 2018. ,
Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates, Cancer Immunol Res, vol.2, pp.756-764, 2014. ,
Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines, J Med Chem, 2019. ,
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy, Nat Commun, vol.8, 1954. ,
TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation, Cell, vol.158, pp.506-521, 2014. ,
HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates, Proc Natl Acad Sci U S A, vol.102, pp.15190-15194, 2005. ,
Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion, Nature medicine, vol.19, pp.465-472, 2013. ,
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia, N Engl J Med, vol.361, pp.1838-1847, 2009. ,
Peptide-Based Therapeutic Cancer Vaccines, 2018. ,
Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience, Chem Soc Rev, vol.39, pp.241-263, 2010. ,
In vivo characterization of the physicochemical properties of polymerlinked TLR agonists that enhance vaccine immunogenicity, Nat Biotechnol, vol.33, pp.1201-1210, 2015. ,
Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction, Biomacromolecules, vol.20, pp.854-870, 2019. ,
Vaccine adjuvants: putting innate immunity to work, Immunity, vol.33, issue.10, pp.362-368 ,
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles, Journal of controlled release : official journal of the Controlled Release Society, vol.112, pp.26-34, 2006. ,
Nanoparticles target distinct dendritic cell populations according to their size, Eur J Immunol, vol.38, pp.1404-1413, 2008. ,
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation, Proc Natl Acad Sci U S A, vol.113, pp.8098-8103, 2016. ,
Structureactivity relationships in human toll-like receptor 7-active imidazoquinoline analogues, J Med Chem, vol.53, pp.4450-4465, 2010. ,
Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity, Nat Mater, vol.18, pp.175-185, 2019. ,
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants, Expert review of vaccines, vol.12, pp.809-819, 2013. ,
Classification and Regression by randomForest, R News, vol.2, pp.18-22, 2002. ,
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities, J Biol Chem, vol.281, pp.12824-12832, 2006. ,
Antigen processing by the proteasome, Nat Rev Mol Cell Biol, vol.2, pp.179-187, 2001. ,
Cu-free click cycloaddition reactions in chemical biology, Chem Soc Rev, vol.39, pp.1272-1279, 2010. ,
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response, Clin Cancer Res, vol.22, pp.2342-2350, 2016. ,
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation, Eur J Immunol, vol.38, pp.1033-1042, 2008. ,
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus, Nat Biotechnol, vol.24, pp.817-819, 2006. ,
Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial, Frontiers in immunology, vol.8, p.1807, 2017. ,
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction, Immunity, vol.46, pp.315-326, 2017. ,
Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants, Curr Opin Immunol, vol.47, pp.1-7, 2017. ,
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses, Nature medicine, vol.22, pp.1402-1410, 2016. ,
Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines, Biomaterials, vol.182, pp.82-91, 2018. ,
A facile approach to enhance antigen response for personalized cancer vaccination, Nat Mater, vol.17, pp.528-534, 2018. ,
A practical approach to the use of nanoparticles for vaccine delivery, J Pharm Sci, vol.95, pp.2738-2750, 2006. ,
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy, Nature, vol.534, pp.396-401, 2016. ,
Designing therapeutic cancer vaccines by mimicking viral infections, Cancer Immunol Immunother, vol.66, pp.203-213, 2017. ,
Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines, Cancer Lett, vol.459, pp.192-203, 2019. ,
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses, Sci Transl Med, vol.8, pp.334-352, 2016. ,
Radiation and Anti-Cancer Vaccines: A Winning Combination, Vaccines (Basel), vol.6, 2018. ,
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nature medicine, vol.13, pp.843-850, 2007. ,
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization, J Immunol, vol.190, pp.2720-2735, 2013. ,
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination, Nature medicine, vol.22, pp.614-623, 2016. ,
SPICE: exploration and analysis of postcytometric complex multivariate datasets, Cytometry. Part A : the journal of the International Society for Analytical Cytology, vol.79, pp.167-174, 2011. ,
Immune epitope database analysis resource, Nucleic Acids Res, vol.40, pp.525-530, 2012. ,
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations, Protein Sci, vol.12, pp.1007-1017, 2003. ,
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method, BMC Bioinformatics, vol.6, 2005. ,
, Nucleic Acids Res, vol.45, pp.635-642, 2017.
0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs, Hum Mutat, vol.37, pp.235-241, 2016. ,
A simple method for displaying the hydropathic character of a protein, J Mol Biol, vol.157, pp.105-132, 1982. ,
COSMIC: the Catalogue Of Somatic Mutations In Cancer, Nucleic Acids Research, vol.47, pp.941-947, 2018. ,